Related Experiment Videos
Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation
Chiharu Uchida1, Seiichi Miwa, Kyoko Kitagawa
1Department of Biochemistry 1, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
The EMBO Journal
|December 4, 2004
Summary
Mdm2, a protein that targets p53 for degradation, also targets the retinoblastoma gene product (pRB) for degradation. This Mdm2-mediated degradation of pRB may contribute to cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Cell Cycle Regulation
Background:
- The retinoblastoma gene product (pRB) is crucial for cell cycle control and tumor suppression.
- Loss of pRB function can lead to carcinogenesis, but the underlying mechanisms are not fully understood.
Purpose of the Study:
- To investigate the mechanism by which pRB is downregulated.
- To determine if Mdm2, a known E3 ubiquitin ligase, interacts with and regulates pRB.
Main Methods:
- In vivo and in vitro ubiquitination assays using wild-type and mutant Mdm2.
- Mdm2 knockout and knockdown experiments.
- Cellular assays measuring pRB-mediated cell morphology changes (flat formation).
- Analysis of Mdm2 and pRB expression in human lung cancer tissues.
Main Results:
- Wild-type Mdm2 directly promoted the ubiquitination and degradation of pRB.
- Mutant Mdm2 lacking RING finger activity stabilized pRB.
- Mdm2 knockout or knockdown led to pRB accumulation.
- Mdm2 inhibited pRB's tumor-suppressive function in Saos-2 cells.
- High Mdm2 expression correlated with low pRB expression in lung cancers.
Conclusions:
- Mdm2 targets pRB for ubiquitin-dependent degradation, thus regulating its function.
- Mdm2-mediated pRB degradation represents a novel mechanism contributing to carcinogenesis.
- Mdm2 is a potential therapeutic target in cancers with pRB downregulation.